Ind-Swift rises on getting renewed approval for Global Business Unit
Ind-Swift is currently trading at Rs. 15.72, up by 0.07 points or 0.45% from its previous closing of Rs. 15.65 on the BSE.
The scrip opened at Rs. 15.74 and has touched a high and low of Rs. 15.78 and Rs. 15.72 respectively. So far 3 shares were traded on the counter.
The BSE group 'B' stock of face value Rs. 2 has touched a 52 week high of Rs. 34.49 on 01-Jan-2025 and a 52 week low of Rs. 12.00 on 09-May-2025.
Last one week high and low of the scrip stood at Rs. 17.44 and Rs. 13.51 respectively. The current market cap of the company is Rs. 85.15 crore.
The promoters holding in the company stood at 55.58%, while Non-Institutions held 44.42% stake in the company.
Ind-Swift has received renewed approval for its 100% Export Oriented Unit (Global Business Unit (GBU)) situated at Punjab for a period of three years from Medicines & Healthcare Products Regulatory Agency (MHRA), London, United Kingdom. The approval is based on the assessment undertaken by the agency of company’s quality metrics and quality systems.
Ind-Swift is Chandigarh based pharmaceutical company, established in 1986 with a mission of winning global customers through innovative pharmaceutical products.
